Days
- :
Hrs
- :
Min
- :
Sec
Frequently Asked Questions
Below you'll find answers to the most common questions you may have about ACT 2025. If you still can't find the answer you're looking for, please contact SSO at advancedtherapies@surgonc.org.General |
||||||||||
|
ACT 2025 will take place at The Scott Resort & Spa in Scottsdale, AZ on February 14-17, 2025. |
||||||||||
Registration |
||||||||||
|
Registration can be completed online via the event website. Please use the following link to view registration categories, price levels, and policies: https://s2.goeshow.com/sso/act/2025/registration.cfm |
||||||||||
|
You do not need to be a member of SSO in order to attend the meeting, though members do receive reduced registration fees. |
||||||||||
|
Registration will be ongoing throughout the meeting. Please view hours below:
|
||||||||||
|
ACT 2025 includes in-person attendance. On-Demand components are not available for this meeting. |
||||||||||
|
Yes, there is an optional pre-course course available for registration designed to benefit the roles of advanced practice providers in the specialty of Surgical Oncology, enhance clinical knowledge of advanced cancer therapies, and provide structured opportunities for interprofessional networking. Attendees will gain a comprehensive Understanding of how APPs contribute to the multidisciplinary care team, utilizing their clinical expertise and knowledge of advanced cancers to enhance outcomes in patient care. |
||||||||||
|
All requests for registration refunds must be sent via email to advancedtherapies@surgonc.org by January 24, 2025, for review. All refunds are subject to a $100 non-refundable processing fee. No refunds will be issued after January 24, 2025.
If you have a serious reason for being unable to attend, you are welcome to petition for an exception to this policy. To do so, please email SSO at advancedtherapies@surgonc.org to explain your situation and include any documentation to support your case (documentation is optional but recommended). These petitions must be submitted by Tuesday, March 4, 2025 (15 business days post meeting) to be considered, and the decision regarding your petition may take up to one month after the event. |
||||||||||
|
Yes, if you are not a U.S. citizen and are planning to attend ACT 2025, advance planning is critical. Citizens of some foreign countries will need a visa to enter the United States and attend ACT 2025. |
||||||||||
|
Image Release
By registering for this event, I consent and authorize SSO to copyright, use and publish any of the images or recordings in any format taken of me during any SSO event. I understand these images may be used for a variety of purposes and may appear on the SSO website, in SSO publications, promotional materials, or any other media now known or to be invented. I agree that SSO will not be responsible for unauthorized use of the images or recordings. I am aware that I am not entitled to any compensation and that the images may appear with or without my name. I also waive any right to inspect or approve any photo, video, or recording taken by SSO or the person or entity designated to do so by SSO.
Consent to 3rd Parties
For nearly a decade, SSO and other organizations have shared conference registration information with exhibitors and industry supporters (excluding email address and fax number). ACCME now requires attendee consent. By checking the following box, you are giving SSO consent to share your name and contact information, including institution, mailing address with any ineligible companies or its agents associated with the SSO Meeting. Ineligible companies are those that cannot be accredited by the ACCME.
Code of Conduct Policy
|
||||||||||
CME/CEU |
||||||||||
|
To claim CME credit and to print certificates after the meeting, please visit the Attendee Portal. Please use your SSO login credentials to sign in. Forgotten passwords can be requested on login screen |
||||||||||
|
Please send any questions about CME/CE credit to education@surgonc.org. Please include "ACT 2025 CME" in the subject line for reference. |
||||||||||
|
The Society of Surgical Oncology is accredited by the Accreditation Council for Continuing Medical Education. |
||||||||||
|
The Society of Surgical Oncology (SSO) designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Surgical oncologists and other health care professionals practicing in the areas of medical, surgical, thoracic, and gynecologic oncology, and gastroenterology, as well as researchers involved in the field of hyperthermia and regionally applied biologic therapies.
Overall Educational Objectives
Upon completion of the activity, learners from several disciplines should be able to:
Disclaimer
The primary purpose of 2025 Advanced Cancer Therapies is educational. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty and the SSO disclaims any and all liability for damages to any individual attending this conference and for all claims which may result from the use of information, technologies, products and/or services discussed at the conference.
|
||||||||||
Accommodations |
||||||||||
|
SSO is pleased to offer a room block at The Scott Resort & Spa. Meeting registration MUST be completed in order to securing housing for ACT 2025. Direct booking links will be provided in your confirmation email upon completion of your registration. |